DOCTORS'
Medical Case Studies
DOCTORS'
Medical Case Studies
Erbitux
Cetuximab
Cetuximab (IMC-C225—marketed under the name Erbitux) is a chimeric (mouse/human) monoclonal antibody, an epidermal growth factor receptor (EGFR) inhibitor, given by intravenous infusion for treatment of metastatic colorectal cancer and head and neck cancer.
Erbitux - List of case studies
- Metastatic, Non Small Cell Lung Cancer – further opinion
-
does NOT recommend biological treatment – NOT Erbitux, and NOT Avastin. Weekly Cycles of Vinorelbine for 2 weeks and ... she does NOT recommend biological treatment – NOT Erbitux, and NOT Avastin. Due to the patient deteriorated condition the ...
- Metastatic colon cancer after 8 years of continous chemotherapy treatment
-
. Eventually she was treated with DEGRAMON and ERBITUX which was halted later to her request. 1.5 years later, CEA ... An year and a half later, treatment with Irinotecan and Erbitux was initiated with partial remission up until the last 2 months where ...
- Drugs
-
Epinephrine Epirubicin Epogen Epogen) Erbitux Erlotinib Erythopoietin injections (Procrit ...
- Metastatic, Non Small Cell Lung Cancer
-
does NOT recommend biological treatment – NOT Erbitux, and NOT Avastin. Weekly Cycles of Vinorelbine for 2 weeks and ... orange, oxycontin, Carboplatin, Navelbine, taxol, ALIMTA, Erbitux, Avastin, Vinorelbine, Vinorelbine,Taxotere, Erlotinib, palliative ...
- Metastatic non small cell lung Cancer
-
does NOT recommend biological treatment – NOT Erbitux , and NOT Avastin . Due to the patient deteriorated condition ... , ,Carboplatin, Diaplatin, Navelbine, Taxol, ALIMTA, Erbitux, Avastin, Vinorelbine, Taxotere, Erlotinib, Tarceva ...